Nvidia Assures Skeptical Investors on AI Mainstream Adoption Boosts Dividend and Announces 80 Billion Buyback Maxim Upgrades Gilead Sciences to Buy What This Could Mean for Investors Enhanced Games the Steroid Olympics Backed by Donald Trump Jr Set for Sunday Debut with Stock Swings Trainline Upgrades FullYear Guidance for Second Time This Year Kazatomprom Reports 17 Production Increase in Third Quarter Government Pledges 120 Million to Support UK Ceramics Industry Mitsubishi UFJ Financial Group MUFG Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income Western Copper and Gold Corporation WRN Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Development Stage RILYT Q1 2024 Earnings Negative EPS and Revenue Omission Signal Challenges Astrana Health Inc Q1 2026 Earnings EPS Falls Short of Estimates Revenue Details Omitted FEIM Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Rally BBAI Q1 2026 Earnings EPS Misses Estimates as Company Navigates AI Market Headwinds Axsome Therapeutics AXSM Holds Near Resistance as Momentum Remains Cautious UiPath PATH Rallies 34 as Automation Stock Tests Resistance Near 1148 DTE Energy Debenture DTB Edges Higher Amid Stable Trading Key Levels to Watch IBM Stock Gains 18 as Shares Approach Key Resistance Technical and Sector Analysis General Purpose Acquisition Corp Warrant GPACW Sees Modest Gain Amid Thin Trading CNTA Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Flat DLTH Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher Solid Biosciences Inc SLDB Q1 2026 Earnings Wider Loss Reported as Pipeline Investment Continues NEN Q4 2024 Earnings Partnership Delivers Strong PerUnit Earnings Amid Quiet Market Reaction GSK Q1 2026 Earnings EPS Surpasses Expectations Amid Solid Operational Performance PEBK Q4 2025 Earnings Strong EPS of 121 Highlights Steady Profitability Diversified Energy Expands Permian Basin Footprint with Maverick Natural Resources Acquisition CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Zentalis Pharmaceuticals ZNTL Faces Resistance Near 426 After Recent Pullback